abstract |
The present invention is a composition for the prevention or treatment of cervical cancer, comprising a lymphotoxin α / β complex (Lmphotoxin α / β Complex, LTα / β) or lymphotoxin β receptor (Lymphotoxin β receptor, LTβ-R) binder as an active ingredient In this regard, by effectively inducing a mucosal immune response, it can be usefully used as a preventive or therapeutic agent for cervical cancer. |